FAUCI Act

Crime and Law Enforcement

house

senate

president

Introduced on May 1, 2024 by Debbie Lesko

Legislation Details

Amends title 18, United States Code, to prohibit former employees of certain health agencies from serving on boards of entities involved in drug, biological product, or device development and research.
Defines terms such as “biological product,” “covered health agency,” “device,” “drug,” and “top official.”
Covered health agencies include the National Institutes of Health, the Food and Drug Administration, and the Centers for Disease Control and Prevention.
Imposes penalties for former top officials of covered health agencies who serve on boards or profit from drugs, biological products, or devices within 8 years after their service ends.
Sets a civil penalty of $250,000 and imprisonment for not more than five years nor less than one year for former employees profiting from a drug, biological product, or device they were involved in approving.
Includes a special rule for certain former Federal employees of covered health agencies, with a compliance period of 6 months from the date of enactment.
Prohibits top officials from submitting applications for patents related to drugs, biological products, or devices invented during or outside the course of their employment while being a top official.
Requires top officials and their spouses to disclose any ownership or interest in such patents within specified time frames after the enactment of the Act or after becoming a top official or the spouse of one.

Last updated 8/10/2024